Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00772759 | Assess Safety, Tolerability and PK of AZD3199 in Japanese | PHASE1 | COMPLETED | 27 | — | — | Oct 1, 2008 | Feb 1, 2009 | May 5, 2009 | 1 | United Kingdom |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dry powder for oral inhalation |
| 2 | PLACEBO_COMPARATOR | Dry powder for oral inhalation |
| Name | Type | Description |
|---|---|---|
| AZD3199 Turbuhaler® | DRUG | 240, 720 and 2160 μ g, single and multiple (o.d. for 12 days) |
| Placebo Turbuhaler® | DRUG | single and multiple (o.d. for 12 days) |
Inclusion Criteria: * Be healthy Japanese volunteers, both of the volunteer's parents, and all grandparents must be Japanese. The volunteer must have been born in Japan, have a valid Japanese passport and must not have lived outside Japan for for more than 5 years. * BMI 18 - 27, Weight 50 - 85 kg ...